Surgical management of rhinosinusitis for the allergist-immunologist

Ann Allergy Asthma Immunol. 2023 Sep;131(3):311-316. doi: 10.1016/j.anai.2023.05.015. Epub 2023 May 21.

Abstract

Chronic rhinosinusitis (CRS) is a common chronic inflammatory disease characterized by inflammation of the sinus, with or without nasal passage inflammation, occurring for more than 12 weeks at a time. CRS has historically been classified in 2 categories: CRS without nasal polyps or CRS with nasal polyps (25%-30% of cases). The mainstay of treatment for CRS with or without nasal polyps is medical management, and options may include a combination of saline irrigation, nasal steroids, allergy medications, antibiotics, oral steroids, and treatment with targeted monoclonal antibodies. Unfortunately, up to 60% of patents report symptoms refractory to maximal medical therapy. As such, a combined approach of surgery and medical therapy may be offered. Endoscopic sinus surgery for CRS is approached in a stepwise fashion, ranging from the simplest technique, such as polyp removal, to more expanded approaches that open the paranasal sinuses and allow gravity-dependent drainage. This review article provides a review and in-depth explanation of various surgical approaches for CRS, including the indications, techniques, and respective outcomes for each one.

Publication types

  • Review

MeSH terms

  • Allergists
  • Chronic Disease
  • Humans
  • Inflammation
  • Nasal Polyps* / drug therapy
  • Nasal Polyps* / surgery
  • Rhinitis* / diagnosis
  • Rhinitis* / surgery
  • Sinusitis* / diagnosis
  • Sinusitis* / surgery
  • Steroids / therapeutic use

Substances

  • Steroids